Cryogenic OGS (544440)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 57.12% and profit growth of 64.75% show strong momentum.
• ROCE of 32.02% indicates highly efficient use of capital.
• Latest quarter net margin of ~28.6% (₹6 Cr profit on ₹21 Cr sales) is exceptional.
• Piotroski F-Score of 7/9 suggests solid financial health.
• PEG ratio of 0.48 implies reasonable valuation relative to growth.

Concerns

• P/E of 29.51 is high in absolute terms, with zero dividend yield.
• Missing critical data: book value, ROE, debt/equity, promoter holding, and 52-week range.
• Small market cap of ₹233 Cr makes it vulnerable to volatility and liquidity issues.
• Sustainability of 57-65% growth is unproven; latest quarter sales of ₹21 Cr is a very small base.

AI Analysis

When I look at Cryogenic OGS, I see a small, fast-growing industrial-products company. The headline numbers are striking: sales up 57.12% and profits up 64.75%. A business that can compound at these rates while earning an ROCE of 32.02% is doing something right. The latest quarter reinforces the picture: ₹21 Cr of sales and ₹6 Cr of net profit, implying a net margin of nearly 28.6%. That is exceptional for an industrial firm and suggests pricing power or a lean cost structure. The Piotroski F-Score of 7/9 also tells me the financials are not just growing on paper; the underlying quality appears solid. At ₹163.05, the market cap is just ₹233 Cr, making this a true small-cap. The P/E of 29.51 is not cheap in absolute terms, but with profit growth of 64.75%, the PEG ratio works out to only 0.48. If that growth is durable, the market is offering a reasonable price for a high-quality compounder. However, I must be honest: critical data is missing. There is no book value, no ROE, no debt-to-equity ratio, no promoter holding, and no 52-week range. As Graham would say, you cannot judge a business properly without knowing its balance sheet. The zero dividend is acceptable for a fast grower, but it means shareholders must depend entirely on capital appreciation. This is a promising fast grower, but the lack of disclosure is a red flag. I would need more information on debt, governance, and order visibility before making a meaningful commitment. For now, I would watch it closely, not chase it blindly.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer